Whitehawk Therapeutics (WHWK) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Whitehawk Therapeutics (WHWK) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | 72.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.20% |
| Dec 31, 2025 | 43.03% |
| Sep 30, 2025 | 42.22% |
| Jun 30, 2025 | -162.40% |
| Mar 31, 2025 | -44.83% |
| Dec 31, 2024 | -12.76% |
| Sep 30, 2024 | 47.51% |
| Jun 30, 2024 | -216.00% |
| Mar 31, 2024 | -237.66% |
| Dec 31, 2023 | -131.61% |
| Sep 30, 2023 | -96.59% |
| Jun 30, 2023 | -48.24% |
| Mar 31, 2023 | -73.47% |
| Dec 31, 2022 | -141.81% |
| Sep 30, 2022 | -165.08% |
| Jun 30, 2022 | 15.07% |
| Mar 31, 2022 | -52.28% |
| Dec 31, 2021 | 21.85% |
| Sep 30, 2021 | -224.81% |
| Jun 30, 2021 | 6.54% |